Display options
Share it on

Front Aging Neurosci. 2015 May 15;7:86. doi: 10.3389/fnagi.2015.00086. eCollection 2015.

Synergistic effects of free radical scavengers and cochlear vasodilators: a new otoprotective strategy for age-related hearing loss.

Frontiers in aging neuroscience

Juan Carlos Alvarado, Verónica Fuentes-Santamaría, Pedro Melgar-Rojas, María Llanos Valero, María Cruz Gabaldón-Ull, Josef M Miller, José M Juiz

Affiliations

  1. Facultad de Medicina, Universidad de Castilla-La Mancha, Instituto de Investigación en Discapacidades Neurológicas (IDINE) Albacete, Spain.
  2. Karolinska Institutet Stockholm, Sweden ; Kresge Hearing Research Institute, University of Michigan Ann Arbor, MI, USA.

PMID: 26029103 PMCID: PMC4432684 DOI: 10.3389/fnagi.2015.00086

Abstract

The growing increase in age-related hearing loss (ARHL), with its dramatic reduction in quality of life and significant increase in health care costs, is a catalyst to develop new therapeutic strategies to prevent or reduce this aging-associated condition. In this regard, there is extensive evidence that excessive free radical formation along with diminished cochlear blood flow are essential factors involved in mechanisms of other stress-related hearing loss, such as that associated with noise or ototoxic drug exposure. The emerging view is that both play key roles in ARHL pathogenesis. Therapeutic targeting of excessive free radical formation and cochlear blood flow regulation may be a useful strategy to prevent onset of ARHL. Supporting this idea, micronutrient-based therapies, in particular those combining antioxidants and vasodilators like magnesium (Mg(2+)), have proven effective in reducing the impact of noise and ototoxic drugs in the inner ear, therefore improving auditory function. In this review, the synergistic effects of combinations of antioxidant free radicals scavengers and cochlear vasodilators will be discussed as a feasible therapeutic approach for the treatment of ARHL.

Keywords: antioxidants; cochlear blood flow; magnesium; oxidative stress; presbyacusis; sensorineural hearing loss; vitamins

References

  1. Arch Intern Med. 2009 Feb 23;169(4):415-6 - PubMed
  2. Hear Res. 2010 Jun 1;264(1-2):70-8 - PubMed
  3. Oxid Med Cell Longev. 2014;2014:582849 - PubMed
  4. Brain Res. 2003 Mar 21;966(2):265-73 - PubMed
  5. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7915-22 - PubMed
  6. Curr Neuropharmacol. 2009 Mar;7(1):65-74 - PubMed
  7. Hear Res. 2013 Sep;303:30-8 - PubMed
  8. Age (Dordr). 2014 Jun;36(3):9653 - PubMed
  9. Clin Otolaryngol Allied Sci. 2004 Jun;29(3):238-41 - PubMed
  10. Korean J Audiol. 2013 Sep;17(2):45-9 - PubMed
  11. Eur Arch Otorhinolaryngol. 2010 Aug;267(8):1179-91 - PubMed
  12. Korean J Audiol. 2013 Sep;17(2):39-44 - PubMed
  13. Transl Res. 2011 Jul;158(1):38-53 - PubMed
  14. J Gerontol A Biol Sci Med Sci. 2011 May;66(5):582-90 - PubMed
  15. Am J Otol. 1989 Jan;10(1):36-41 - PubMed
  16. Cell Signal. 2012 May;24(5):981-90 - PubMed
  17. Gerontology. 2012;58(6):490-6 - PubMed
  18. J Assoc Res Otolaryngol. 2014 Jun;15(3):375-93 - PubMed
  19. Nature. 2006 Oct 19;443(7113):787-95 - PubMed
  20. Plant Physiol. 2006 Jun;141(2):312-22 - PubMed
  21. J Speech Lang Hear Res. 2002 Dec;45(6):1249-61 - PubMed
  22. Free Radic Biol Med. 2007 May 1;42(9):1454-63 - PubMed
  23. Arch Otorhinolaryngol. 1982;236(2):139-46 - PubMed
  24. Eur Arch Otorhinolaryngol. 2000;257(1):10-6 - PubMed
  25. Hear Res. 2007 Apr;226(1-2):203-8 - PubMed
  26. Neuroscience. 2005;134(2):633-42 - PubMed
  27. J Am Acad Audiol. 2003 May-Jun;14(4):202-12 - PubMed
  28. Ann Otol Rhinol Laryngol. 1972 Jun;81(3):364-76 - PubMed
  29. Hear Res. 2009 Feb;248(1-2):39-47 - PubMed
  30. Magnes Res. 2002 Mar;15(1-2):17-25 - PubMed
  31. Lancet. 2005 Sep 24-30;366(9491):1111-20 - PubMed
  32. Hear Res. 2011 Dec;282(1-2):10-24 - PubMed
  33. Clin Interv Aging. 2012;7:159-63 - PubMed
  34. Hear Res. 2007 Apr;226(1-2):92-103 - PubMed
  35. Exp Gerontol. 2011 Jun;46(6):413-25 - PubMed
  36. Hear Res. 2000 Nov;149(1-2):138-46 - PubMed
  37. Brain Res. 2006 May 26;1091(1):89-102 - PubMed
  38. Ann Otol Rhinol Laryngol. 1993 Jan;102(1 Pt 2):1-16 - PubMed
  39. Adv Exp Med Biol. 2012;942:311-27 - PubMed
  40. Hear Res. 2010 Jun 1;264(1-2):98-107 - PubMed
  41. Acta Otolaryngol. 2005 Mar;125(3):235-43 - PubMed
  42. Mol Cell. 2012 Oct 26;48(2):158-67 - PubMed
  43. Neurobiol Aging. 2012 May;33(5):1010.e15-6 - PubMed
  44. Otolaryngol Head Neck Surg. 2010 Sep;143(3):429-34 - PubMed
  45. ISRN Otolaryngol. 2013 Jun 27;2013:430625 - PubMed
  46. Nagoya J Med Sci. 1999 May;62(1-2):1-9 - PubMed
  47. Laryngoscope. 2000 May;110(5 Pt 1):727-38 - PubMed
  48. Geriatr Gerontol Int. 2014 Jan;14(1):40-53 - PubMed
  49. Hear Res. 2000 Mar;141(1-2):199-219 - PubMed
  50. Otolaryngol Head Neck Surg. 2003 Nov;129(5):463-70 - PubMed
  51. Ann N Y Acad Sci. 1999 Nov 28;884:226-32 - PubMed
  52. Ageing Res Rev. 2002 Jun;1(3):331-43 - PubMed
  53. Hear Res. 2007 Apr;226(1-2):114-25 - PubMed
  54. Front Aging Neurosci. 2014 Mar 05;6:29 - PubMed
  55. Am J Otolaryngol. 1994 Jan-Feb;15(1):26-32 - PubMed
  56. Nephrol Dial Transplant. 2011 Dec;26(12):4073-8 - PubMed
  57. Hear Res. 2013 Sep;303:12-9 - PubMed
  58. Audiol Neurootol. 2003 Jul-Aug;8(4):207-21 - PubMed
  59. Hear Res. 2007 Apr;226(1-2):22-43 - PubMed
  60. J Biol Chem. 2012 Feb 10;287(7):4434-40 - PubMed
  61. Otol Neurotol. 2011 Aug;32(6):919-25 - PubMed
  62. Oxid Med Cell Longev. 2014;2014:573208 - PubMed
  63. Brain Res. 1999 Jan 9;815(2):317-25 - PubMed
  64. PLoS One. 2011;6(10):e26728 - PubMed
  65. Hear Res. 2008 Jul;241(1-2):26-33 - PubMed
  66. Physiol Rev. 2002 Jul;82(3):601-36 - PubMed
  67. Biochem Biophys Res Commun. 2009 Dec 18;390(3):394-8 - PubMed

Publication Types